Peizhe Li

Title: Peizhe Li: Innovator in Biomedicine

Introduction

Peizhe Li is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly in the development of innovative solutions for viral infections. His work focuses on enhancing the stability and immunogenicity of viral proteins, which can lead to improved vaccine formulations.

Latest Patents

Peizhe Li holds a patent for "Mutants of respiratory syncytial virus fusion proteins." This patent relates to an improved mutant of the respiratory syncytial virus (RSV) fusion (F) protein. The mutant can form a trimeric structure without introducing a heterologous trimerization domain. Through various mutation designs, such as releasing internal electrostatic repulsion, deleting the furin cleavage site, truncating the C-terminal domain, and introducing interchain disulfide bonds, the protein is stabilized in the pre-fusion conformation. This enhanced stability makes the mutant highly immunogenic when used as a vaccine or vaccine component. It can induce the production of a high level of neutralizing antibodies in immunized animals, making it a valuable tool for the prevention or treatment of RSV infection. Additionally, it can be used as a reagent for the detection of RSV.

Career Highlights

Peizhe Li is associated with Yikang Biotech (Suzhou) Co., Ltd., where he continues to advance his research in biomedicine. His innovative work has positioned him as a key figure in the development of effective vaccines against viral infections.

Collaborations

Peizhe Li collaborates with notable colleagues, including Lei Chen and Yujiao Song, who contribute to his research endeavors and help drive forward the mission of Yikang Biotech.

Conclusion

Peizhe Li's contributions to the field of biomedicine, particularly through his patent on RSV fusion proteins, highlight his role as an innovator in vaccine development. His work not only enhances our understanding of viral proteins but also paves the way for more effective treatments against viral infections.